China Health Technology Group Terminates 52% Stake Acquisition Deal

China Health Technology Group Holding (HKG:1069) will terminate the acquisition deal for a 52% stake in a target company, according to a Hong Kong bourse filing on Monday. The termination is mutually

MT NewswiresApr 9 16:28

China Health Technology Group (01069.HK) terminated the acquisition of 52% shares in Liuba Jiashisen Traditional Chinese Medicine Comprehensive Development

Gelonghui, April 8, 丨 China Health Technology Group (01069.HK) announced the acquisition of 52% of the shares in Liuba Jiashisen Traditional Chinese Medicine Comprehensive Development. After signing the share sale agreement, the company then carried out detailed due diligence and other work on the seller. However, at the company's request, the seller failed to provide satisfactory due diligence documentation to the company. Following friendly negotiations between the company and the seller, the contracting parties decided to terminate the acquisition. The Board believes that terminating the agreement will not have any significant adverse impact on the Group's business, operations, or financial position.

Gelonghui FinanceApr 8 22:14

中國健康科技集團：二零二三年中期報告

Futu NewsMar 28 22:51 · Announcements

China Health Technology Returns to Profit in Fiscal H1

China Health Technology Group (HKG:1069) returned to a profit of 201.4 million yuan in the six months ended Dec. 31, 2023, from a loss of 1.2 million yuan in the year-ago period, a Friday filing said.

MT NewswiresMar 1 16:30

China Health Technology Group (01069) announced interim results with net profit of 201 million yuan

China Health Technology Group (01069) announced results for the six months ended December 31, 2023, with revenue of 19...

Zhitong FinanceMar 1 06:19

CN HEALTH TECH: ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 31 DECEMBER 2023

Futu NewsMar 1 06:06 · Announcements